Epilepsy Clinical Trials in Philadelphia

Showing 61-80 of 116 trials

Staccato Alprazolam and Photoparoxysmal Response

NCT02351115

The purpose of this study is to determine whether people who usually have photosensitive epilepsy will show a reduction in epileptic activity when they take a single dose of Staccato Alprazolam as compared to placebo.

Epilepsy

Alexza Pharmaceuticals, Inc.5 participantsStarted Jan 2015

Boise, Idaho, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

NCT00334958

To evaluate the effect of rufinamide on total partial seizure frequency in adolescent and adult participants (12 to 80 years, inclusive) with refractory partial onset seizures maintained on a maximum of 3 stable antiepileptic drugs (AEDs).

Epilepsy

Eisai Inc.356 participantsStarted Feb 2006

Mobile, Alabama, United States • Northport, Alabama, United States • Phoenix, Arizona, United States +74 more locations

Staccato Alprazolam and Photoparoxysmal Response

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Epilepsy Trials in Other Cities

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Pharmacokinetics of Anti-epileptic Drugs in Obese Children

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Does Use of Rapid Response EEG Impact Clinical Decision Making

A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Other Conditions in Philadelphia